In 2020, Kristin Peck succeeded Juan Ramon Alaix as the CEO of Zoetis Inc. A Fortune 500 company, Zoetis makes animal health products, such as vaccines and medicines for livestock and pets. Earlier, it was a part of Pfizer but now it runs independently. Zoetis CEO Kristin Peck’s topmost priority is to set goals and […]

After the exit of Donald E. Morel, Jr., Eric M. Green became the CEO of West Pharmaceutical Services, Inc. The American pharmaceutical company offers injectable solutions and services. West Pharma CEO Eric Green is dedicated to building a strong and committed management team and creating strategies for further developments. With his experience and incredible leadership […]

In 2021, Kevin Ali became the CEO of Organon & Co. It is an American healthcare company dedicated to serving healthcare needs and benefits to women, covering several health issues. Organon CEO Kevin Ali had been instrumental in the creation of Organon. After seeing the detrimental condition of women’s health around the world, he decided […]

Bill Anderson succeeded the German pharma giant Bayer’s veteran Werner Baumann to occupy the post of CEO in 2023. He is also the company’s board chairman. Bayer CEO Bill Anderson has a substantial background in developing processes and products, marketing, sales, finance, and general management. He enjoys his time everywhere and with everyone, whether in […]

Olivier Brandicourt’s departure from the French pharmaceutical company Sanofi led to the appointment of Paul Hudson to the post of CEO in 2019. Sanofi CEO Paul Hudson wants to revolutionize every aspect of vaccines and medicines, from discovery to accessibility. The leader follows the path of inclusivity, equity, and diversity. He is also committed to […]

Thomas Schinecker replaced the long-time executive Severin Schwan at Swiss drugmaker Roche Holding AG in 2023. Roche CEO Thomas Schinecker’s promotion is based on his performance. Under him, the company’s diagnostics arm witnessed massive growth during the pandemic. As the top official, his keen attention is on developing drugs. He heavily invests in research and […]

Dame Emma Walmsley is the first female CEO at the British pharmaceutical company GSK plc from 2017. She replaced Andrew Witty. GSK CEO Emma Walmsley’s appointment fueled the speculation that the company would prioritize its consumer operation. However, she stressed that producing and commercializing new medicines will be the focus. Under her guidance, the company […]

Harvard-trained physician Vasant (Vas) Narasimhan took control of Europe’s leading drug-making company Novartis AG from its eight-year-old chief Joseph Jimenez in 2018. Novartis CEO Vas Narasimhan is responsible for the company’s strategic decisions and cultural revamp. He is on a mission to turn Novartis into a dedicated medicines company to provide treatments for diseases through […]